These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33879319)

  • 61. Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19.
    Kumar D; Jahan S; Khan A; Siddiqui AJ; Redhu NS; Wahajuddin ; Khan J; Banwas S; Alshehri B; Alaidarous M
    Mol Neurobiol; 2021 Jul; 58(7):3417-3434. PubMed ID: 33715108
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications.
    Higashikuni Y; Liu W; Obana T; Sata M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769508
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acute stroke care during the COVID-19 pandemic: difficult, but not impossible!
    Maldonado Slootjes S; Hammer F; Leempoel J; Peeters A
    Acta Neurol Belg; 2020 Oct; 120(5):1257-1258. PubMed ID: 32638268
    [No Abstract]   [Full Text] [Related]  

  • 65. SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.
    Swain O; Romano SK; Miryala R; Tsai J; Parikh V; Umanah GKE
    J Neurosci; 2021 Jun; 41(25):5338-5349. PubMed ID: 34162747
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.
    Bavishi C; Bonow RO; Trivedi V; Abbott JD; Messerli FH; Bhatt DL
    Prog Cardiovasc Dis; 2020; 63(5):682-689. PubMed ID: 32512122
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis.
    Misra S; Kolappa K; Prasad M; Radhakrishnan D; Thakur KT; Solomon T; Michael BD; Winkler AS; Beghi E; Guekht A; Pardo CA; Wood GK; Hsiang-Yi Chou S; Fink EL; Schmutzhard E; Kheradmand A; Hoo FK; Kumar A; Das A; Srivastava AK; Agarwal A; Dua T; Prasad K
    Neurology; 2021 Dec; 97(23):e2269-e2281. PubMed ID: 34635561
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Analysis of Nationwide Stroke Patient Care in Times of COVID-19 Pandemic in Germany.
    Richter D; Eyding J; Weber R; Bartig D; Grau A; Hacke W; Krogias C
    Stroke; 2021 Jan; 52(2):716-721. PubMed ID: 33356382
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hyperthrombotic Milieu in COVID-19 Patients.
    Kamel MH; Yin W; Zavaro C; Francis JM; Chitalia VC
    Cells; 2020 Oct; 9(11):. PubMed ID: 33142844
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients.
    De Michele M; d'Amati G; Leopizzi M; Iacobucci M; Berto I; Lorenzano S; Mazzuti L; Turriziani O; Schiavo OG; Toni D
    J Hematol Oncol; 2022 Aug; 15(1):108. PubMed ID: 35974404
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of COVID-19 Pandemic on a Regional Stroke Thrombectomy Service in the United Kingdom.
    Kwan J; Brown M; Bentley P; Brown Z; D'Anna L; Hall C; Halse O; Jamil S; Jenkins H; Kalladka D; Patel M; Rane N; Singh A; Taylor E; Venter M; ; Banerjee S
    Cerebrovasc Dis; 2021; 50(2):178-184. PubMed ID: 33311017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Can cilia provide an entry gateway for SARS-CoV-2 to human ciliated cells?
    Buqaileh R; Saternos H; Ley S; Aranda A; Forero K; AbouAlaiwi WA
    Physiol Genomics; 2021 Jun; 53(6):249-258. PubMed ID: 33855870
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Insult to Injury-Potential Contribution of Coronavirus Disease-19 to Neuroinflammation and the Development of HIV-Associated Neurocognitive Disorders.
    Williams ME; Fielding BC
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):601-609. PubMed ID: 32993321
    [TBL] [Abstract][Full Text] [Related]  

  • 74. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature.
    Tan YK; Goh C; Leow AST; Tambyah PA; Ang A; Yap ES; Tu TM; Sharma VK; Yeo LLL; Chan BPL; Tan BYQ
    J Thromb Thrombolysis; 2020 Oct; 50(3):587-595. PubMed ID: 32661757
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neuroinflammation and COVID-19 Ischemic Stroke Recovery-Evolving Evidence for the Mediating Roles of the ACE2/Angiotensin-(1-7)/Mas Receptor Axis and NLRP3 Inflammasome.
    Che Mohd Nassir CMN; Zolkefley MKI; Ramli MD; Norman HH; Abdul Hamid H; Mustapha M
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328506
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preceding infection and risk of stroke: An old concept revived by the COVID-19 pandemic.
    South K; McCulloch L; McColl BW; Elkind MS; Allan SM; Smith CJ
    Int J Stroke; 2020 Oct; 15(7):722-732. PubMed ID: 32618498
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients.
    Cantador E; Núñez A; Sobrino P; Espejo V; Fabia L; Vela L; de Benito L; Botas J
    J Thromb Thrombolysis; 2020 Oct; 50(3):543-547. PubMed ID: 32519165
    [TBL] [Abstract][Full Text] [Related]  

  • 79. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 80. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.
    Manolis AS; Manolis TA; Manolis AA; Papatheou D; Melita H
    J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):12-24. PubMed ID: 32924567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.